Form 4: Klaviyo Chief Technology Officer Allen Chaves Executes Stock Option and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Allen Chaves, Chief Technology Officer of Klaviyo, Inc., exercised stock options and sold shares of Series A Common Stock under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On August 12 and 13, 2024, Allen Chaves, the Chief Technology Officer of Klaviyo, Inc., engaged in transactions involving the company's stock.
- Chaves exercised a stock option to acquire 130,000 shares of Series B Common Stock at a price of $3.055 per share.
- He then converted these shares into Series A Common Stock.
- Chaves also sold 119,491 shares of Series A Common Stock at a weighted average price of $31.63 and 10,509 shares at a weighted average price of $31.17.
- These sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 21, 2023.
- Following these transactions, Chaves directly owns 1,158,693 shares of Series B Common Stock and 239,475 shares of Series A Common Stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about the transactions.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to monitor potential alignment between management's actions and company performance.
Comparison to Industry Standards
- Executive compensation packages often include stock options to align management interests with shareholder value.
- Rule 10b5-1 trading plans are a common tool for insiders to diversify their holdings while avoiding accusations of insider trading, similar to practices seen at companies like Salesforce and Adobe.
- The reported transactions are typical for executives at publicly traded companies.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the sale of shares by a company executive.
- The impact is likely minimal given the pre-arranged nature of the sales under the Rule 10b5-1 trading plan.
Key Dates
| Date | Description |
|---|---|
| 2023-11-21 | Date of adoption of Rule 10b5-1 trading plan |
| 2024-08-12 | Date of stock option exercise and initial stock sales |
| 2024-08-13 | Date of additional stock option exercise |
| 2030-04-15 | Expiration date of stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.